Ignite Creation Date:
2024-05-05 @ 10:31 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01124734
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2010-03-04
Brief Title:
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Sponsor:
Organization:
Milton S Hershey Medical Center